ESC 365 - Impact of atrial fibrillation on biomarkers predicting severity of coronary artery disease in patients with suspected coronary heart disease: baseline data from the ANOX study

ESC Premium Access

Impact of atrial fibrillation on biomarkers predicting severity of coronary artery disease in patients with suspected coronary heart disease: baseline data from the ANOX study

Session: Poster session 3 - Biomarkers - Heart Failure

Topic: Atrial fibrillation (AF)

Speaker: Doctor H. Wada (Kyoto, JP)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Hiromichi Wada

National Hospital Organization Kyoto Medical Center, Kyoto (Japan)

0 follower

7 more presentations in this session

Plasma trimethylamine-N-oxide is associated with atrial fibrillation

Speaker: Doctor G. Svingen (Bergen, NO)

Elevated levels of BNP and fibroblast growth factor 23 in patients with atrial fibrillation : an analysis of 40 cardiovascular biomarkers in 667 unselected hospitalized patients.

Speaker: Doctor Y. Purmah (Birmingham, GB)

NT-proBNP is a more sensitive and specific biomarker for the prediction of future atrial fibrillation than for forthcoming onset of heart failure: results from the observational DIAST-CHF study

Speaker: Miss S. Werhahn (Berlin, DE)

Circulating lipopolysaccharides and risk of major adverse cardiovascular events in atrial fibrillation: association with mediterranean diet adherence

Speaker: Associate Professor D. Pastori (Rome, IT)

Effect of rivaroxaban on coagulation and inflammation biomarkers: results from an X-VeRT substudy

Speaker: Doctor Y. Purmah (Birmingham, GB)

Access the full session

Poster session 3 - Biomarkers - Heart Failure

Speakers: Doctor H. Wada, Doctor G. Svingen, Doctor Y. Purmah, Miss S. Werhahn, Associate Professor D. Pastori...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources